Echinocandin antifungal drug resistance

T.M. Rogers, E.M. Johnson, Carol Anne Munro

Research output: Contribution to journalArticlepeer-review


The recent introduction of the echinocandins to clinical practice represents a welcome addition to the antifungal armamentarium. This new class of drugs with their novel mode of antifungal action have several advantages over existing agents. They are most active against the principal invasive fungal pathogens Candida and Aspergillus spp, they have low toxicity for patients, and they have potential value in combination therapy.
Original languageEnglish
Pages (from-to)99-105
JournalJournal of Invasive Fungal Infections
Issue number3
Publication statusPublished - Jan 2007


Dive into the research topics of 'Echinocandin antifungal drug resistance'. Together they form a unique fingerprint.

Cite this